Efavir 600 Tablet
Marketer
Cipla Ltd
Salt Composition
Efavirenz (600mg)
Overview Efavir 600 Tablet
Tenofovir disoproxil fumarate 600mg tablets are classified as antiretroviral medications. They're indicated for HIV (human immunodeficiency virus) treatment, preventing the progression to AIDS (acquired immunodeficiency syndrome). This medication manages HIV, strengthening your immune response. Tenofovir disoproxil fumarate 600mg tablets lessen the likelihood of HIV-related complications and extend life expectancy. Administration is flexible, with or without food, typically in conjunction with other antiretroviral agents. Consistent adherence to the prescribed regimen maximizes efficacy and minimizes the risk of drug resistance. Continuous use is crucial unless your physician advises otherwise. Frequent side effects may include headache, nausea, vomiting, abdominal discomfort, tiredness, diarrhea, and skin rashes. While generally mild, persistent or troublesome symptoms should be reported to your doctor. Seek immediate medical attention for severe skin reactions or signs of liver impairment. Pre-existing skin, liver, or kidney conditions should be disclosed prior to commencing treatment. Regular blood tests monitoring blood cell counts and liver function are usually required. Alcohol consumption should be avoided due to potential liver toxicity. Consult your doctor before use if pregnant or breastfeeding. Avoid unprotected sex and sharing personal items if you are HIV-positive. Discuss safe sex practices, such as condom use, with your doctor to prevent HIV transmission.
Uses of Efavir 600 Tablet
Managing HIV disease
Major Benefits of Efavir 600 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Efavir 600 Tablets should be administered on an empty stomach.
Common Side effects of Efavir 600 Tablet:
- Headache
- Nausea
- Dizziness
- Vomiting
- Increased liver enzymes
- Insomnia (difficulty in sleeping)
- Sleepiness
- Abnormal dreams
- Anxiety
- Itching
- Difficulty in paying attention
- Rash
- Abdominal pain
- Diarrhea
- Depression
- Fatigue
- Pain
- Decreased appetite
How to use Efavir 600 Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Efavir 600 Tablet on an empty stomach.
How Efavir 600 Tablet works:
Efavir 600mg tablets inhibit HIV replication within human cells, halting further viral production.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Efavir 600 Tablet requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Efavir 600 Tablet during pregnancy carries a confirmed risk to the fetus. Prescribing it is uncommon except in life-threatening circumstances where potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Based on available data, the use of Efavir 600 Tablet while breastfeeding appears to pose minimal risk to the infant. Studies in humans indicate negligible harm to the nursing child.
DrivingUNSAFE
Taking Efavir 600 mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Use of Efavir 600 Tablet in individuals with kidney impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Efavir 600 mg tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. Efavir 600 mg tablets are contraindicated for those with moderate to severe hepatic dysfunction.
What if you forget to take Efavir 600 Tablet :
NA
Facts to Know About Efavir 600 Tablet
| Label | Value |
|---|---|
| Chemical Category | Non-nucleoside reverse transcriptase inhibitor |
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
| Actions | Non-nucleoside reverse transcriptase inhibitors |







